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Coexistence of early microinvasive endometrioid
adenocarcinoma and CIN3 in the uterine cervix in




Simultaneous occurrence of early microinvasive endometrioid adenocarcinoma (EMEA) and CIN 3 in the uterine
cervix is very rare in Japan. A 32-year-old Japanese woman was pointed out to have atypical cells in the cervical
cytology. Colposcopic examination revealed irregular lesions in the cervix, and a biopsy showed simultaneous
EMEA and CIN3. The EMEA was grade I and CIN3 corresponded to severe dysplasia/carcinoma in situ.
Hysterectomy and lymph nodes dissection were performed. Grossly, mucosal irregularity and erosion were seen in
the cervix. No tumor formation was recognized. The cervix was examined by serial sections. Microscopically, there
were a tiny adenocarcinoma (0.5 cm in diameter and 0.3 cm in depth) and broad areas of CIN3. The
adenocarcinoma was EMEA without mucins. The EMEA was FIGO stage 1A1. Immunohistochemically, the EMEA
was positive for pancytokeratins (AE1/2 +++, CAM5.2 ++), cytokeratin (CK) 34bE12 +, CK5/6 +, CK7 +, CK18 +++,
CK19 ++, CA19-9 +, CA125 +++, p53 +, ER +++, PgR +++, while it was negative for CK8, CK14, CK20, EMA,
vimentin, CEA, desmin, smooth muscle actin, p63, chromogranin, synaptophysin, CD56, CD68, HER2/neu, MUC1,
MUC2, MUC5AC, and MUC6. The CIN 3 was positive for pancytokeratins (AE1/2 +++, CAM5.2 +), cytokeratin (CK)
34bE12 +++, CK5/6 +++, CK7 +, EMA, CA19-9 +, CA125 +, p53 +, p63 +++, ER +++, and MUC1 +, while it was
negative for CK8, CK14, CK18, CK19, CK20, vimentin, CEA, desmin, smooth muscle actin, chromogranin,
synaptophysin, CD56, CD68, PgR, HER2/neu, MUC2, MUC5AC and MUC6. The lymph nodes showed no metastatic
lesions (0/34). In conclusion, the author reported a rare case of simultaneous EMEA and CIN 3 with extensive
immunohistochemical findings.
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Introduction
Malignant neoplasms of the uterine cervix are frequent
in Japan. Most of them are squamous cell carcinoma
and cervical intraepithelial neoplasm (CIN), and adeno-
carcinoma and its precursor lesions are rare in Japan.
Adenocarcinoma of the uterine cervix was classified into
adenocarcinoma NOS, mucinous adenocarcinoma, endo-
metrioid adenocarcinoma, clear cell adenocarcinoma, ser-
ous adenocarcinoma mesonephric adenocarcinoma, early
microinvasive adenocarcinoma, and adenocarcinoma in
situ [1]. The mucinous adenocarcinoma was subclassified
into endocervical, intestinal, signet-ring cell, minimal
deviation, and villoglandular subtypes [1]. Glandular dys-
plasia equivalent to squamous dysplasia is also present.
More than 90% of uterine tumorous lesions are squa-
mous cell carcinoma and its precursor lesions. The pre-
cursor lesions of the squamous cell carcinoma had
traditionally been called dysplasia (mild, moderate, and
severe) and carcinoma in situ (CIS). Recently, they have
been termed as cervical intraepithelial neoplasm (CIN) or
squamous intraepithelial lesions (SIL) [1]. CIN is categor-
ized as CIN 1-3, and SIL as low grade SIL (CIN 1) and
high grade SIL(CIN2-3/CIS) (HGSIL) [1]. These lesions
are known to be frequently associated with sexual inter-
courses and human papilloma virus (HPV) infection [1].
According to WHO [1], adenocarcinoma is associated
with CIN in about 40% of cases. However, Brown et al
[2] reported that only 1 case of adenocarcinoma was
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of adenocarcinoma and CIN 3 is very rare. The author
herein reports a case of simultaneous early microinva-
sive endometrioid adenocarcinomna (EMEC) and CIN 3
in a young Japanese woman.
Case report
A 32-year-old Japanese woman was found to have atypi-
cal cells in the cervical cytology at routine check. Colpo-
scopic examination revealed irregular lesions in the
cervix. A biopsy revealed simultaneous adenocarcinoma
(Figure 1) and CIN3 (Figure 2). The adenocarcinoma
have grade I atypia and CIN3 corresponded to severe
dysplasia/carcinoma in situ.
Hysterectomy and lymph nodes dissection were per-
formed. Grossly, mucosal irregularity and erosion were
seen in the cervix (Figure 3). No tumor formation was
recognized. The cervix was examined by serial sections.
There were a tiny adenocarcinoma (0.5 cm in diameter
and 0.3 cm in depth) (Figure 4) and broad areas of
CIN3 (Figure 5). Both lesions are separate, and no
merges between both lesions were seen. The adenocarci-
noma was EMEA without mucins, as revealed by nega-
tive alcian blue/PAS staining. The lymph nodes were
negative for metastasis (0/34). No metastatic foci were
found in the body. The EMEA was FIGO stage 1A1.
An immunohistochemical study was performed with
the use of DAKO Envision method (Dako Corp.,
Glostrup, Denmark), as described previously [3-7]. The
immunohistochemical results are shown in Table 1.
Immunohistochemically, the EMEA was positive for
pancytokeratins (AE1/2 +++, CAM5.2 ++), cytokeratin
(CK) 34bE12 +, CK5/6 +, CK7 +, CK18 +++(Figure 6),
CK19 ++, CA19-9 +, CA125 +++ (Figure 7), p53 +, ER
+++, PgR +++, while it was negative for CK8, CK14,
CK20, EMA, vimentin, CEA, desmin, smooth muscle
actin, p63, chromogranin, synaptophysin, CD56, CD68,
HER2/neu, MUC1, MUC2, MUC5AC, and MUC6. The
CIN 3 was positive for pancytokeratins (AE1/2 +++,
CAM5.2 +), cytokeratin (CK) 34bE12 +++ (Figure 8),
CK5/6 +++, CK7 +, EMA, CA19-9 +, CA125 +, p53 +,
p63 +++ (Figure 9), ER +++, and MUC1 + (Figure 10),
while it was negative for CK8, CK14, CK18, CK19,
CK20, vimentin, CEA, desmin, smooth muscle actin,
chromogranin, synaptophysin, CD56, CD68, PgR, HER2/
neu, MUC2, MUC5AC, and MUC6. The patient is now
free from tumor 4 months after the operation.
Discussion
The adenocarcinoma in the present case was early
microinvasive with width of 0.5 cm and depth of 0.3
cm. Histologically, the adenocarcinoma resembled endo-
metrial endometrioid adenocarcinoma (grade 1), and
negative for mucins. Therefore, the adenocarcinoma was
EMEA [1]. The diagnosis of CIN 3 is apparent in the
present case [1].
Figure 1 Biopsy of uterine cervix. The biopsy shows atypical glands with hyperchromatic nuclei and with structural atypia. This lesion is
regarded as adenocarcinoma. HE, ×100.
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Page 2 of 9Figure 2 Biopsy of uterine cervix. The biopsy shows atypical squamous lesion. The atypical cells showed hyperchromatic nuclei and occupy all
layers. The polarity and stratification are lost. The lesion was regarded as CIN3. HE, ×100.
Figure 3 Gross features of resected uterus. The cervix shows irregularity and erosions. No apparent tumor is seen.
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Page 3 of 9Figure 4 Microscopic features of the resected uterus. The adenocarcinoma component The adenocarcinoma is endometrioid
adenocarcinoma. The carcinoma is small with mild invasion. HE ×50.
Figure 5 Microscopic features of the resected uterus. The CIN3 component. CIN3 without invasion is seen. HE ×50.
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coexist in the uterine cervix [8-13]; there are several case
reports of this in the English literature [8-13]. From the
standpoint of CIN, Brown et al [2] reported that 16 cases
of cervical glandular atypia and only 1 case adenocarci-
noma in situ were found in 105 cases of CIN 3. From the
standpoint of cervical adenocarcinoma, Maier and Norris
[9] reported that 99 cases of CIN were detected in 230
cases of cervical adenocarcinoma. About half of such
cases were CIN 2 or CIN 3 [9]. There is only one report
that there is an association of adenocarcinoma in situ
and cervical squamous cell carcinoma [10]. However,
cases of simultaneous adenocarcinoma and CIN3 are
very rare in the English literature [10,14-19]. In addition,
cases of simultaneous early microinvasive adenocarci-
noma and CIN3 are very rare [17,18]. Furthermore, cases
of simultaneous endometrioid adenocarcinoima and
CIN3 are extremely rare. Therefore, the present case of
coexistence of EMEA and CIN3 appears extremely rare.
In the present study, the cervical lesion is typical
CIN3, HGSIL, or CIS. No invasion was recognized. The
histological features fulfillt h ed i a g n o s i so fC I N3[ 1 ] .
The adenocarcinoma element in the present study was
of EMEA negative for mucins [1]. In both elements,
adequate structural and cytological atypia regarded as
malignant was recognized. The positive immunoreaction
of p53 protein in the present EMEA and CIN3 strongly
suggests that both lesions in the present study are
malignant.
There have been few immunohistochemical studies in
simultaneous squamous neoplasm and adenocarcinoma
in the uterine cervix [10]. The present study extensively
examined the immunoprofile of EMEA and CIN3. The
EMEA and CIN3 showed different immunoprofile,
Table 1 Immunohistochemical reagents and results
Results
Antigens Antibodies (clone) Sources EMEA. CIN3
Pancytokeratin AE1/3 Dako Corp. Glostrup, Denmark +++ +++
Pancytokeratin CAM5.2 Beckton-Dickinson, CA, USA ++ +
HMWCK 34bE12 Dako + +++
CK5/6 D5/16 Dako + +++
CK7 N1626 Dako + +
CK8 DC10 Dako - -
CK14 LL002 Novocastra, Newcastle upon type, UK - -
CK 18 DC10 Dako +++ -
CK 19 RCK 108 Progen, Heidelberg, Germany ++ -
CK 20 K20.8 Dako - -
EMA E29 Dako - +
Vimentin Vim 3B4 Dako - -
CEA polyclonal Dako - -
CA19-9 NS19-9 TBF Lab, Tokyo Japan + +
CA125 NS125 TFB Lab +++ +
Desmin D33 Dako - -
ASMA 1A4 Dako - -
p53 protein DO-7 Dako + +
p63 4A4 Dako - +++
Chromogranin DAK-A3 Dako - -
Synaptophysin Polyconal Dako - -
CD56 UJ13A Dako - -
CD68 KP-1 Dako - -
ER M7047 Dako +++ +++
PgR 1A6 Novocastra +++ -
HER2/neu CB11 Ventana Japan, Tokyo - -
MUC1 Ma695 Novocastra - +
MUC2 CCp58 Novocastra - -
MUC5AC CLH2 Novocastra - -
MUC6 CLH5 Novocastra - -
+++, strongly positive. ++, moderately positive. +, mildly positive. -, negative. EMEA, early microinvasive endometrioid adenocarcinoma. CIN3, cervical
intraepithelial neoplasm grade 3. HMWCK, high molecular weight cytokeratin. CK, cytokeratin. EMA, epithelial membrane antigen. CEA, carcinoembryonic antigen.
CA19-9, carbohydrate antigen 19-9. CA125, carbohydrate antigen 125. ASMA, a-smooth muscle antigen. ER, estrogen receptor. PgR, progesterone receptor.
Terada Diagnostic Pathology 2011, 6:51
http://www.diagnosticpathology.org/content/6/1/51
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profiling of EMEA showed predominant presence of low
molecular weight cytokeratin, while CIN3 high-molecu-
lar weight cytokeratin. Since squamous lesions express
high-molecular weight CK while adenocarcinoma low-
molecular weight cytokeratin [20], the present data indi-
cate the CIN3 is squamous lesions and EMEA is adeno-
carcinoma. The presence of p63 in CIN3 but not in
EMEA indicates that CIN3 was squamous lesion and
EMEA is not, since p63 is known to be expressed in
Figure 6 Immunohistochemical features. The adenocarcinoma component is strongly positive for cytokeratin 18. ×100.
Figure 7 Immunohistochemical features. The adenocarcinoma component is strongly positive for CA125. ×100.
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[21]. Both components were negative for CK14, CK17,
and CK20, suggesting that these three CKs are not
expressed in either lesion. EMA was positive in CIN3,
but negative in EMEA, suggesting that EMA is
expressed only in CIN lesions. CA125 was strongly posi-
tive in EMA and mildly positive in CIN, suggesting that
CA125 is mainly expressed in adenocarcinoma element
rather than CIN. CA19-9 was mildly expressed in both
EMEA and CIN3, suggesting that both lesions have a
Figure 8 Immunohistochemical features. The CIN3 component was strongly positive for cytokeratin 34bE12. ×100.
Figure 9 Immunohistochemical features. The CIN3 component was strongly positive for p63. ×100.
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positive in both components, suggesting that p53 gene
is mutated in both components and that both compo-
nents are malignant. Both components were strongly
positive for ER, being compatible with the presence of
ER of female genital organs. However, PgR was strongly
positive for EMEA but negative in CIN3, suggesting the
presence of PgR in EMEA, but not in CIN. Interestingly,
MUC 1 was present in CIN3 but was absent in EMEA.
MUC2, MUC5AC and MUC6 were negative in both
components. MUC is mucin core protein gene product
so that it was previously anticipated that MUCs are pre-
sent in EMEA. These results indicate CIN3 may be posi-
tive for MUC1 and EMEA was negative for MUCs. Both
elements were negative for chromogranin, synaptophy-
sin, and CD56, indicating that both components do not
show neuroendocrine features. Both components were
negative for vimentin, desmin, and a-smooth mucle
actin, indicating that these three mesenchymal antigens
were absent in EMEA and CIN3. CEA was negative for
both components, suggesting that EMEA may be nega-
tive for CEA. CD68 was negative in both components,
indicating no histiocytic differentiation. Both compo-
nents were negative for HER2/neu, suggesting that both
components were negative for this receptor.
In summary, the author presented a case of simulta-
neous EMEA and CIN3 of the uterine cervix in a 32-
year-old Japanese woman with an emphasis on immuno-
histochemical findings.
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